2011
DOI: 10.1007/s10549-011-1349-x
|View full text |Cite
|
Sign up to set email alerts
|

Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands

Abstract: Improved survival of patients with primary distant metastatic breast cancer in the period of 1995 -2008. A nationwide population-based study in the Netherlands 1 AbstractPurpose In this study changes in prognosis for more than 8000 patients with primary distant metastatic breast cancer were analyzed, using nation-wide data of the Netherlands Cancer Registry. Besides the roll of systemic treatment, the effect of surgery of the primary tumor was evaluated. Methods

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
45
0
5

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 64 publications
(51 citation statements)
references
References 21 publications
1
45
0
5
Order By: Relevance
“…Several studies have used different statistical methods to determine the prognostic factors of secondary breast metastasis. According to the literature, estrogen receptor (ER), progesterone receptor (PR), lymph node involvement ratio (LNR), cathepsin-D (Cath-D), tumor protein 53 (p53) , human epidermal growth factor receptor type 2 (Her2 also known as ERBB2 or HER-2/neu), tumor size, age at diagnosis, chemotherapy, and axillary nodal status at the time of diagnosis of the primary tumor are the most important prognostic factors with different impact on progression and metastases of breast cancer to various organs (Rochefort et al, 1990;Veronesi et al, 1993;Garcia et al, 1996;Inoue et al, 1998;Balleine et al, 1999;Rochefort and Liaudent-coopman, 1999;Selzner et al, 2000;Evans et al, 2004;Colleoni et al, 2005;Truong et al, 2005;Voogd et al, 2005;Weigelt et al, 2005;Palmieria et al, 2006Palmieria et al, , 2007Altundag et al, 2007;Sezgin et al, 2007;Wadasadawala et al, 2007;Gao et al, 2009;Koizumi et al, 2010;Ruiterkamp et al, 2011;Senkus et al, 2013).…”
Section: Exploring Factors Related To Metastasis Free Survival In Brementioning
confidence: 99%
See 2 more Smart Citations
“…Several studies have used different statistical methods to determine the prognostic factors of secondary breast metastasis. According to the literature, estrogen receptor (ER), progesterone receptor (PR), lymph node involvement ratio (LNR), cathepsin-D (Cath-D), tumor protein 53 (p53) , human epidermal growth factor receptor type 2 (Her2 also known as ERBB2 or HER-2/neu), tumor size, age at diagnosis, chemotherapy, and axillary nodal status at the time of diagnosis of the primary tumor are the most important prognostic factors with different impact on progression and metastases of breast cancer to various organs (Rochefort et al, 1990;Veronesi et al, 1993;Garcia et al, 1996;Inoue et al, 1998;Balleine et al, 1999;Rochefort and Liaudent-coopman, 1999;Selzner et al, 2000;Evans et al, 2004;Colleoni et al, 2005;Truong et al, 2005;Voogd et al, 2005;Weigelt et al, 2005;Palmieria et al, 2006Palmieria et al, , 2007Altundag et al, 2007;Sezgin et al, 2007;Wadasadawala et al, 2007;Gao et al, 2009;Koizumi et al, 2010;Ruiterkamp et al, 2011;Senkus et al, 2013).…”
Section: Exploring Factors Related To Metastasis Free Survival In Brementioning
confidence: 99%
“…3-10% of patients have distant metastases and, in general, there is no cure for these patients and all treatments are palliative in nature (Ruiterkamp et al, 2011). These rates are higher for developing countries where the first diagnosis is at later stages.…”
Section: Exploring Factors Related To Metastasis Free Survival In Brementioning
confidence: 99%
See 1 more Smart Citation
“…Apesar dos avanços na detecção precoce e na compreensão das bases moleculares da doença, 10% das pacientes com câncer de mama possuem metástase à distância no momento do diagnósti-co. 3 Além disso, de 20 a 30% das pacientes diagnosticadas com câncer de mama em estágio inicial apresentam recorrência na forma de metástase à distância. 4,5,6 Ao contrário do que sugeriam os primeiros modelos de doença metastática, segundo os quais a disseminação do tumor ocorria em está-gios tardios da carcinogênese, os estudos mais recentes mostram que a metástase se dá de forma mais precoce durante a progressão do tumor, mesmo nas pacientes diagnosticadas em estágios iniciais, justificando a necessidade de um maior estudo da doença metastática nessas pacientes.…”
Section: Introductionunclassified
“…In some types of cancer, the liver metastasis lesion is a target of surgical treatment. For instance, surgical resection of hepatic metastasis achieves longer median survival in colorectal and breast cancer patients [1,2]. However, even if the hepatic lesions are surgically treated, the prognosis of the patients is not satisfactory.…”
Section: Introductionmentioning
confidence: 99%